MITRASSIST LIFESCIENCES LIMITED

MITRASSIST LIFESCIENCES LIMITED

Shanghai,China

MITRASSIST LIFESCIENCES LIMITED

Shanghai,China

favorite supplier

verified Copper Member
MITRASSIST LIFESCIENCES LIMITED
favorite supplier

MITRASSIST LIFESCIENCES LIMITED

Shanghai,China

Scan QR code

Access to mobile station

Clear All
Alternate Text

MitraFix TMVR System

FOB Price : Get a Price/Quote

Min.Order : 1 Piece(s)

Certification : OTHER

Brand Name : MitraFix

Payment Terms : L/C,T/T,D/P,WesternUnion,MoneyGram

share :

product information

  • brand name : MitraFix

  • certification : OTHER

  • min.order : 1 Piece(s)

  • warranty : N/A

  • payment terms : L/C,T/T,D/P,WesternUnion,MoneyGram

  • Packaging : Set

  • Specification : N/A

  • place of origin : China

product description

MitraFix, our transcatheter mitral valve replacement system is the only one product in the world to achieve transcatheter mitral valve replacement under ultrasound guidance and can be delivered through both transapical and transfemoral paths.

With the fastest clinical progress, it is expected to be the first product to be approved in China,and  of the first three approved in the worldwide.

At present, MitraFix  is in the clinical trial of registration at present in China.

People who viewed this also viewed

  • Drug Coated Balloon

    FOB Price :

    Min.Order : 1 Piece(s)

  • Sikelia TAVR System

    FOB Price :

    Min.Order : 1 Piece(s)

  • ReDS System V2.7

    FOB Price :

    Min.Order : 1 Vial(s)

  • MitraFix TMVR System

    FOB Price :

    Min.Order : 1 Piece(s)

MITRASSIST LIFESCIENCES LIMITED

Copper verified

Business Type Manufacturer

Country / Region Shanghai,China

Main Products Electro-cardiac Monitor, Intervention Consumables

Main Markets

MitraFix TMVR System
share :

product information

product description

MitraFix, our transcatheter mitral valve replacement system is the only one product in the world to achieve transcatheter mitral valve replacement under ultrasound guidance and can be delivered through both transapical and transfemoral paths.

With the fastest clinical progress, it is expected to be the first product to be approved in China,and  of the first three approved in the worldwide.

At present, MitraFix  is in the clinical trial of registration at present in China.

Recommend

Join Free

Create New Account

Leave your contact information for the suppliers. If you're our member, Please Sign In to use your account information.

Sign in